LAVA-1207
Lava Therapeutics
['crpc', 'gu ', 'lava therap']
lava therapeutics announces initial data from the ongoing phase 1/2a clinical trial of lava-1207 in therapy refractory mcrpc at the 2023 asco gu symposium 
We provide a balanced view on small cap biotech equities.